These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23921430)

  • 1. Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsies.
    Noll BD; Coller JK; Somogyi AA; Morris RG; Russ GR; Hesselink DA; Van Gelder T; Sallustio BC
    Ther Drug Monit; 2013 Oct; 35(5):617-23. PubMed ID: 23921430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of an LC-MS/MS method for the quantification of mycophenolic acid in human kidney transplant biopsies.
    Md Dom ZI; Noll BD; Coller JK; Somogyi AA; Russ GR; Hesselink DA; van Gelder T; Sallustio BC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 945-946():171-7. PubMed ID: 24342510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of cyclosporine A in rat tissues and human kidney transplant biopsies--a method suitable for small (<1 mg) samples.
    Noll BD; Coller JK; Somogyi AA; Morris RG; Russ GR; Hesselink DA; van Gelder T; Sallustio BC
    Ther Drug Monit; 2011 Dec; 33(6):688-93. PubMed ID: 22105584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in liver biopsies after hepatic transplantation: correlation with histopathologic staging of rejection.
    Capron A; Lerut J; Verbaandert C; Mathys J; Ciccarelli O; Vanbinst R; Roggen F; De Reyck C; Lemaire J; Wallemacq PE
    Ther Drug Monit; 2007 Jun; 29(3):340-8. PubMed ID: 17529892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
    Tempestilli M; Di Stasio E; Basile MR; Elisei F; Antonini M; Ettorre GM; Iappelli M; Pucillo LP
    Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of tacrolimus and three demethylated metabolites in human whole blood using LC-ESI-MS/MS.
    Dubbelboer IR; Pohanka A; Said R; Rosenborg S; Beck O
    Ther Drug Monit; 2012 Apr; 34(2):134-42. PubMed ID: 22406653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells.
    Capron A; Musuamba F; Latinne D; Mourad M; Lerut J; Haufroid V; Wallemacq PE
    Ther Drug Monit; 2009 Apr; 31(2):178-86. PubMed ID: 19057467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients.
    Lemaitre F; Antignac M; Fernandez C
    Clin Biochem; 2013 Oct; 46(15):1538-41. PubMed ID: 23454394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid and simultaneous determination of tacrolimus (FK506) and diltiazem in human whole blood by liquid chromatography-tandem mass spectrometry: application to a clinical drug-drug interaction study.
    Li JL; Wang XD; Wang CX; Fu Q; Liu LS; Huang M; Zhou SF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(1):111-8. PubMed ID: 18417431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study.
    Musuamba FT; Mourad M; Haufroid V; Delattre IK; Verbeeck RK; Wallemacq P
    Ther Drug Monit; 2009 Dec; 31(6):734-42. PubMed ID: 19855314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a combined enzymatic-digestion/mass spectrometry assay for Tacrolimus quantitation in cardiac biopsies.
    Molinaro M; Pellegrini C; Cattadori B; De Gregori S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122215. PubMed ID: 32615534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of tacrolimus colloidal dispersion for inhalation.
    Watts AB; Peters JI; Talbert RL; O'Donnell KP; Coalson JJ; Williams RO
    Eur J Pharm Biopharm; 2011 Feb; 77(2):207-15. PubMed ID: 21130874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of tacrolimus in human whole blood in kidney transplant recipients using a rapid and specific LC-MS/MS method.
    Hieu TB; Dung NM; Toan PQ; Kien TQ; Van Duc N; Thang LV; Van Tran P; Hop VQ; Phuong NM; Ben NH; Van Khoi N; Nghia TT; Dung VD; Van Thinh N; Hang DTT; Van Men C; Long DD; Su HX
    J Clin Lab Anal; 2023 Aug; 37(15-16):e24958. PubMed ID: 37621139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of Tacrolimus Concentration and Protein Expression of P-Glycoprotein in Single Human Renal Core Biopsies.
    Krogstad V; Vethe NT; Robertsen I; Hasvold G; Ose AD; Hermann M; Andersen AM; Chan J; Skauby M; Svensson MHS; Åsberg A; Christensen H
    Ther Drug Monit; 2018 Jun; 40(3):292-300. PubMed ID: 29578937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
    Bazin C; Guinedor A; Barau C; Gozalo C; Grimbert P; Duvoux C; Furlan V; Massias L; Hulin A
    J Pharm Biomed Anal; 2010 Dec; 53(4):997-1002. PubMed ID: 20674215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney and Liver Tissue Tacrolimus Concentrations in Adult Transplant Recipients-The Influence of the Whole Blood and Tissue Concentrations on Efficiency of Treatment during Immunosuppressive Therapy.
    Bodnar-Broniarczyk M; Durlik M; Bączkowska T; Czerwińska K; Marszałek R; Pawiński T
    Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS; Taylor PJ; Salm P; Morris RG
    Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference.
    Wallemacq P; Armstrong VW; Brunet M; Haufroid V; Holt DW; Johnston A; Kuypers D; Le Meur Y; Marquet P; Oellerich M; Thervet E; Toenshoff B; Undre N; Weber LT; Westley IS; Mourad M
    Ther Drug Monit; 2009 Apr; 31(2):139-52. PubMed ID: 19177031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid and sensitive method to determine tacrolimus in rat whole blood using liquid-liquid extraction with mild temperature ultrasonication and LC-MS/MS.
    Park JS; Cho HR; Kang MJ; Choi YS
    Arch Pharm Res; 2016 Jan; 39(1):73-82. PubMed ID: 26589688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
    Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.